Preclinical Studies
IND-Enabling Preclinical Studies
As your programme approaches clinical development, we provide the critical studies required for regulatory submissions.
ImmunitasBio is collaborated with multiple GLP laboratories in India, our IND-enabling capabilities include:
- Preclinical efficacy studies
- Pharmacokinetic (PK) evaluations
- Regulatory toxicology support
- Quality and analytical testing
- Regulatory-grade reporting and documentation
This ensures your programme is prepared for IND submission and regulatory review.
